Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
December-2021 Volume 24 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
December-2021 Volume 24 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

NEP1‑40 promotes myelin regeneration via upregulation of GAP‑43 and MAP‑2 expression after focal cerebral ischemia in rats

Corrigendum in: /10.3892/mmr.2023.12945
  • Authors:
    • Hong Zhao
    • Zhen-Dong Liu
    • Yong-Bo Zhang
    • Xiao-Yu Gao
    • Cui Wang
    • Yi Liu
    • Xun-Fen Wang
  • View Affiliations / Copyright

    Affiliations: Department of Neurology, Dalian Municipal Central Hospital Affiliated to Dalian Medical University, Dalian, Liaoning 116033, P.R. China, Department of General Medicine, Central Hospital Affiliated to Shaoxing University, Shaoxing, Zhejiang 312000, P.R. China, Department of Neurology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, P.R. China, Department of Neurology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, Shandong 264000, P.R. China, Department of Neurology, Dalian Medical University, Dalian, Liaoning 116033, P.R. China
    Copyright: © Zhao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 844
    |
    Published online on: October 11, 2021
       https://doi.org/10.3892/mmr.2021.12484
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Axon regeneration after lesions to the central nervous system (CNS) is largely limited by the presence of growth inhibitory molecules expressed in myelin. Nogo‑A is a principal inhibitor of neurite outgrowth, and blocking the activity of Nogo‑A can induce axonal sprouting and functional recovery. However, there are limited data on the expression of Nogo‑A after CNS lesions, and the mechanism underlying its influences on myelin growth remains unknown. The aim of the present study was to observe the time course of Nogo‑A after cerebral ischemia/reperfusion in rats using immunohistochemistry and western blot techniques, and to test the effect of its inhibitor Nogo extracellular peptide 1‑40 (NEP1‑40) on neural plasticity proteins, growth‑associated binding protein 43 (GAP‑43) and microtubule associated protein 2 (MAP‑2), as a possible mechanism underlying myelin suppression. A classic model of middle cerebral artery occlusion (MCAO) was established in Sprague‑Dawley rats, which were divided into three groups: i) MCAO model group; ii) MCAO + saline group; and iii) MCAO + NEP1‑40 group. Rats of each group were divided into five subgroups by time points as follows: days 1, 3, 7, 14 and 28. Animals that only received sham operation were used as controls. The Nogo‑A immunoreactivity was located primarily in the cytoplasm of oligodendrocytes. The number of Nogo‑A immunoreactive cells significantly increased from day 1 to day 3 after MCAO, nearly returning to the control level at day 7, increased again at day 14 and decreased at day 28. Myelin basic protein (MBP) immunoreactivity in the ipsilateral striatum gradually decreased from day 1 to day 28 after ischemia, indicating myelin loss appeared at early time points and continuously advanced during ischemia. Then, intracerebroventricular infusion of NEP1‑40, which is a Nogo‑66 receptor antagonist peptide, was administered at days 1, 3 and 14 after MCAO. It was observed that GAP‑43 considerably increased from day 1 to day 7 and then decreased to a baseline level at day 28 compared with the control. MAP‑2 expression across days 1‑28 significantly decreased after MCAO. Administration of NEP1‑40 attenuated the reduction of MBP, and upregulated GAP‑43 and MAP‑2 expression at the corresponding time points after MCAO compared with the MCAO + saline group. The present results indicated that NEP1‑40 ameliorated myelin damage and promoted regeneration by upregulating the expression of GAP‑43 and MAP‑2 related to neuronal and axonal plasticity, which may aid with the identification of a novel molecular mechanism of restriction in CNS regeneration mediated by Nogo‑A after ischemia in rats.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

View References

1 

Filbin MT: Myelin-associated inhibitors of axonal regeneration in the adult mammalian CNS. Nat Rev Neurosc. 4:703–713. 2003. View Article : Google Scholar

2 

Baldwin KT and Giger RJ: Insights into the physiological role of CNS regeneration inhibitors. Front Mol Neurosci. 8:232015. View Article : Google Scholar

3 

Chen MS, Huber AB, van der Haar ME, Frank M, Schnell L, Spillmann AA, Christ F and Schwab ME: Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature. 403:434–439. 2000. View Article : Google Scholar

4 

Liu H, Ng CE and Tang BL: Nogo-A expression in mouse central nervous system neurons. Neurosci Lett. 328:257–260. 2002. View Article : Google Scholar

5 

Jin WL, Liu YY, Liu HL, Yang H, Wang Y, Jiao XY and Ju G: Intraneuronal localization of Nogo-A in the rat. J Comp Neurol. 458:1–10. 2003. View Article : Google Scholar

6 

Llorens F, Gil V and del Río JA: Emerging functions of myelin-associated proteins during development, neuronal plasticity, and neurodegeneration. FASEB J. 25:463–475. 2011. View Article : Google Scholar

7 

Huber AB, Weinmann O, Brösamle C, Oertle T and Schwab ME: Patterns of Nogo mRNA and protein expression in the developing and adult rat and after CNS lesions. J Neurosci. 22:3553–3567. 2002. View Article : Google Scholar

8 

Zhou C, Li Y, Nanda A and Zhang JH: HBO suppresses Nogo-A, Ng-R, or RhoA expression in the cerebral cortex after global ischemia. Biochem Biophys Res Commun. 309:368–376. 2003. View Article : Google Scholar

9 

Eslamboli A, Grundy RI and Irving EA: Time-dependent increase in Nogo-A expression after focal cerebral ischemia in marmoset monkeys. Neurosci Lett. 408:89–93. 2006. View Article : Google Scholar

10 

Fournier AE, GrandPre T and Strittmatter SM: Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration. Nature. 409:341–346. 2001. View Article : Google Scholar

11 

Otero-Ortega L, Gómez-de Frutos MC, Laso-García F, Sánchez-Gonzalo A, Martínez-Arroyo A, Díez-Tejedor E and Gutiérrez-Fernández M: NogoA Neutralization promotes axonal restoration after white matter injury in subcortical stroke. Sci Rep. 7:94312017. View Article : Google Scholar

12 

Cheatwood JL, Emerick AJ and Kartje GL: Neuronal plasticity and functional recovery after ischemic stroke. Top Stroke Rehabil. 15:42–50. 2008. View Article : Google Scholar

13 

Benowitz LI and Routtenberg A: GAP-43: An intrinsic determinant of neuronal development and plasticity. Trends Neurosci. 20:84–91. 1997. View Article : Google Scholar

14 

Frey D, Laux T, Xu L, Schneider C and Caroni P: Shared and unique roles of CAP23 and GAP43 in actin regulation, neurite outgrowth, and anatomical plasticity. J Cell Biol. 149:1443–1454. 2000. View Article : Google Scholar

15 

Emery DL, Raghupathi R, Saatman KE, Fischer I, Grady MS and McIntosh TK: Bilateral growth-related protein expression suggests a transient increase in regenerative potential following brain trauma. J Comp Neurol. 424:521–531. 2000. View Article : Google Scholar

16 

Schmidt-Kastner R, Bedard A and Hakim A: Transient expression of GAP-43 within the hippocampus after global brain ischemia in rat. Cell Tissue Res. 288:225–238. 1997. View Article : Google Scholar

17 

Matesic DF and Lin RC: Microtubule-associated protein 2 as an early indicator of ischemia-induced neurodegeneration in the gerbil forebrain. J Neurochem. 63:1012–1020. 1994. View Article : Google Scholar

18 

Kitagawa K, Matsumoto M, Niinobe M, Mikoshiba K, Hata R, Ueda H, Handa N, Fukunaga R, Isaka Y, Kimura K, et al: Microtubule-associated protein 2 as a sensitive marker for cerebral ischemic damage-immunohistochemical investigation of dendritic damage. Neuroscience. 31:401–411. 1989. View Article : Google Scholar

19 

Johnson GV and Jope RS: The role of microtubule-associated protein 2 (MAP-2) in neuronal growth, plasticity, and degeneration. J Neurosci Res. 33:505–512. 1992. View Article : Google Scholar

20 

Zimmermann M: Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 16:109–110. 1983. View Article : Google Scholar

21 

Longa EZ, Weinstein PR, Carlson S and Cummins R: Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 20:84–91. 1989. View Article : Google Scholar

22 

Mao L, Jia J, Zhou X, Xiao Y, Wang Y, Mao X, Zhen X, Guan Y, Alkayed NJ and Cheng J: Delayed administration of a PTEN inhibitor BPV improves functional recovery after experimental stroke. Neuroscience. 231:272–281. 2013. View Article : Google Scholar

23 

Tu H, Deng L, Sun Q, Yao L, Han JS and Wan Y: Hyperpolarization-activated, cyclic nucleotide-gated cation channels: Roles in the differential electrophysiological properties of rat primary afferent neurons. J Neurosci Res. 76:713–722. 2004. View Article : Google Scholar

24 

Zhao H, Gao XY, Liu ZH, Lin JW, Wang SP, Wang DX and Zhang YB: Effects of the transcription factor Olig1 on the differentiation and remyelination of oligodendrocyte precursor cells after focal cerebral ischemia in rats. Mol Med Rep. 20:4603–4611. 2019.

25 

Mao L, Huang M, Chen SC, Li YN, Xia YP, He QW, Wang MD, Huang Y, Zheng L and Hu B: Endogenous endothelial progenitor cells participate in neovascularization via CXCR4/SDF-1 axis and improve outcome after stroke. CNS Neurosci Ther. 20:460–468. 2014. View Article : Google Scholar

26 

Huang S, Huang D, Zhao J and Chen L: Electroacupuncture promotes axonal regeneration in rats with focal cerebral ischemia through the downregulation of Nogo-A/NgR/RhoA/ROCK signaling. Exp Ther Med. 14:905–912. 2017. View Article : Google Scholar

27 

Cao Y, Shumsky JS, Sabol MA, Kushner RA, Strittmatter S, Hamers FP, Lee DH, Rabacchi SA and Murray M: Nogo-66 receptor antagonist peptide (NEP1-40) administration promotes functional recovery and axonal growth after lateral funiculus injury in the adult rat. Neurorehabil Neural Repair. 22:262–278. 2008. View Article : Google Scholar

28 

Zhu WW, Ma XL, Guo AL, Zhao HY and Luo HH: Neuroprotective effects of NEP1-40 and fasudil on Nogo-A expression in neonatal rats with hypoxic-ischemic brain damage. Genet Mol Res. 10:2987–2995. 2011. View Article : Google Scholar

29 

Niederöst B, Oertle T, Fritsche J, McKinney RA and Bandtlow CE: Nogo-A and myelin-associated glycoprotein mediate neurite growth inhibition by antagonistic regulation of RhoA and Rac1. J Neurosci. 22:10368–10376. 2002. View Article : Google Scholar

30 

Papadopoulos CM, Tsai SY, Cheatwood JL, Bollnow MR, Kolb BE, Schwab ME and Kartje GL: Dendritic plasticity in the adult rat following middle cerebral artery occlusion and Nogo-a neutralization. Cereb Cortex. 16:529–536. 2006. View Article : Google Scholar

31 

Liu Q, Lv HW, Yang S, He YQ, Ma QR and Liu J: NEP1-40 alleviates behavioral phenotypes and promote oligodendrocyte progenitor cell differentiation in the hippocampus of cuprizone-induced demyelination mouse model. Neurosci Lett. 725:1348722020. View Article : Google Scholar

32 

Boghdadi AG, Teo L and Bourne JA: The involvement of the myelin-associated inhibitors and their receptors in CNS plasticity and injury. Mol Neurobiol. 55:1831–1846. 2018. View Article : Google Scholar

33 

Jacobson RD, Virag I and Skene JH: A protein associated with axon growth, GAP43 is widely distributed and developmentally regulated in rat CNS. J Neurosci. 6:1843–1855. 1986. View Article : Google Scholar

34 

Hsu JY, Stein SA and Xu XM: Temporal and spatial distribution of growth-associated molecules and astroglial cells in the rat corticospinal tract during development. J Neurosci Res. 80:330–340. 2005. View Article : Google Scholar

35 

Dijk F, Bergen AA and Kamphuis W: GAP-43 expression is upregulated in retinal ganglion cells after ischemia/reperfusion-induced damage. Exp Eye Res. 84:858–867. 2007. View Article : Google Scholar

36 

Gregersen R, Christensen T, Lehrmann E, Diemer NH and Finsen B: Focal cerebral ischemia induces increased myelin basic protein and growth-associated protein-43 gene transcription in peri-infarct areas in the rat brain. Exp Brain Res. 138:384–392. 2001. View Article : Google Scholar

37 

Gorup D, Bohaček I, Miličević T, Pochet R, Mitrečić D, Križ J and Gajović S: Increased expression and colocalization of GAP43 and CASP3 after brain ischemic lesion in mouse. Neurosci Lett. 597:176–182. 2015. View Article : Google Scholar

38 

Zhu X, Wang P, Liu H, Zhan J, Wang J, Li M, Zeng L and Xu P: Changes and significance of SYP and GAP-43 expression in the hippocampus of CIH rats. Int J Med Sci. 16:394–402. 2019. View Article : Google Scholar

39 

Masliah E, Fagan AM, Terry RD, DeTeresa R, Mallory M and Gage FH: Reactive synaptogenesis assessed by synaptophysin immunoreactivity is associated with GAP-43 in the dentate gyrus of the adult rat. Exp Neurol. 113:131–142. 1991. View Article : Google Scholar

40 

Hulsebosch CE, DeWitt DS, Jenkins LW and Prough DS: Traumatic brain injury in rats results in increased expression of Gap-43 that correlates with behavioral recovery. Neurosci Lett. 255:83–86. 1998. View Article : Google Scholar

41 

Ceber M, Sener U, Mihmanli A, Kilic U, Topcu B and Karakas M: The relationship between changes in the expression of growth associated protein-43 and functional recovery of the injured inferior alveolar nerve following transection without repair in adult rats. J Craniomaxillofac Surg. 43:1906–1913. 2015. View Article : Google Scholar

42 

Aigner L, Arber S, Kapfhammer JP, Lauz T, Schneider C, Botteri F, Brenner HR and Caroni P: Overexpression of the neural growth-associated protein GAP-43 induces nerve sprouting in the adult nervous system of transgenic mice. Cell. 183:269–278. 1995. View Article : Google Scholar

43 

Wiche G: High-Mr microtubule-associated proteins: Properties and functions. Biochem J. 259:1–12. 1989. View Article : Google Scholar

44 

Dehmelt L and Halpain S: The MAP2/Tau family of microtubule-associated proteins. Genome Biol. 6:2042005. View Article : Google Scholar

45 

Goodson HV and Jonasson EM: Microtubules and microtubule-associated proteins. Cold Spring Harb Perspect Biol. 10:a0226082018. View Article : Google Scholar

46 

Rosenstein JM: Diminished expression of microtubule-associated protein (MAP-2) and beta-tubulin as a putative marker for ischemic injury in neocortical transplants. Cell Transplant. 4:83–91. 1995. View Article : Google Scholar

47 

Dawson DA and Hallenbeck JM: Acute focal ischemia-induced alterations in MAP2 immunostaining: Description of temporal changes and utilization as a marker for volumetric assessment of acute brain injury. J Cereb Blood Flow Metab. 16:170–174. 1996. View Article : Google Scholar

48 

Li Y, Jiang N, Powers C and Chopp M: Neuronal damage and plasticity identified by microtubule-associated protein 2, growth-associated protein 43, and cyclin D1 immunoreactivity after focal cerebral ischemia in rats. Stroke. 29:1972–1980; discussion 1980-1. 1998. View Article : Google Scholar

49 

Malinak C and Silverstein FS: Hypoxic-ischemic injury acutely disrupts microtubule-associated protein 2 immunostaining in neonatal rat brain. Biol Neonate. 69:257–267. 1996. View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Zhao H, Liu Z, Zhang Y, Gao X, Wang C, Liu Y and Wang X: NEP1‑40 promotes myelin regeneration via upregulation of GAP‑43 and MAP‑2 expression after focal cerebral ischemia in rats Corrigendum in /10.3892/mmr.2023.12945. Mol Med Rep 24: 844, 2021.
APA
Zhao, H., Liu, Z., Zhang, Y., Gao, X., Wang, C., Liu, Y., & Wang, X. (2021). NEP1‑40 promotes myelin regeneration via upregulation of GAP‑43 and MAP‑2 expression after focal cerebral ischemia in rats Corrigendum in /10.3892/mmr.2023.12945. Molecular Medicine Reports, 24, 844. https://doi.org/10.3892/mmr.2021.12484
MLA
Zhao, H., Liu, Z., Zhang, Y., Gao, X., Wang, C., Liu, Y., Wang, X."NEP1‑40 promotes myelin regeneration via upregulation of GAP‑43 and MAP‑2 expression after focal cerebral ischemia in rats Corrigendum in /10.3892/mmr.2023.12945". Molecular Medicine Reports 24.6 (2021): 844.
Chicago
Zhao, H., Liu, Z., Zhang, Y., Gao, X., Wang, C., Liu, Y., Wang, X."NEP1‑40 promotes myelin regeneration via upregulation of GAP‑43 and MAP‑2 expression after focal cerebral ischemia in rats Corrigendum in /10.3892/mmr.2023.12945". Molecular Medicine Reports 24, no. 6 (2021): 844. https://doi.org/10.3892/mmr.2021.12484
Copy and paste a formatted citation
x
Spandidos Publications style
Zhao H, Liu Z, Zhang Y, Gao X, Wang C, Liu Y and Wang X: NEP1‑40 promotes myelin regeneration via upregulation of GAP‑43 and MAP‑2 expression after focal cerebral ischemia in rats Corrigendum in /10.3892/mmr.2023.12945. Mol Med Rep 24: 844, 2021.
APA
Zhao, H., Liu, Z., Zhang, Y., Gao, X., Wang, C., Liu, Y., & Wang, X. (2021). NEP1‑40 promotes myelin regeneration via upregulation of GAP‑43 and MAP‑2 expression after focal cerebral ischemia in rats Corrigendum in /10.3892/mmr.2023.12945. Molecular Medicine Reports, 24, 844. https://doi.org/10.3892/mmr.2021.12484
MLA
Zhao, H., Liu, Z., Zhang, Y., Gao, X., Wang, C., Liu, Y., Wang, X."NEP1‑40 promotes myelin regeneration via upregulation of GAP‑43 and MAP‑2 expression after focal cerebral ischemia in rats Corrigendum in /10.3892/mmr.2023.12945". Molecular Medicine Reports 24.6 (2021): 844.
Chicago
Zhao, H., Liu, Z., Zhang, Y., Gao, X., Wang, C., Liu, Y., Wang, X."NEP1‑40 promotes myelin regeneration via upregulation of GAP‑43 and MAP‑2 expression after focal cerebral ischemia in rats Corrigendum in /10.3892/mmr.2023.12945". Molecular Medicine Reports 24, no. 6 (2021): 844. https://doi.org/10.3892/mmr.2021.12484
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team